Composition
Each ml contains Oxytetracycline 300mg, Flunixin Meglumine 20mg.
Indications
Indicated primarily for the treatment of bovine respiratory disease associated with Mannheimia haemolytica where an anti-inflammatory and anti-pyretic effect is required.
In addition, a wide range of organisms are known to be sensitive in vitro to oxytetracycline, including Pasteurella spp, Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas. The product may therefore be of use in the treatment of disease in cattle caused by such organisms where an anti-inflammatory and antipyretic effect is required.
Dosage and administration
Indicated for deep intramuscular administration to cattle. The recommended dosage is 1 ml per 10 kg bodyweight (equivalent to 2 mg/kg flunixin and 30 mg/kg oxytetracycline) on a single occasion.
Maximum volume per injection site: 15ml.
If concurrent treatment is administered use a separate injection site.
Adverse reactions
The use of tetracyclines during the period of tooth and bone development, including late pregnancy, may lead to discolouration.
Although the product is well tolerated, occasionally a local reaction of a transient nature may be observed.
Contraindications
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hypersensitivity to the product.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Do not administer other NSAIDs concurrently, or within 24 hours of each other.
Concurrent use of potentially nephrotoxic drugs should be avoided.
Do not exceed the stated dose or duration of treatment.
Withdrawal period
Cattle may be slaughtered for human consumption only after 35 days from the last treatment.
Not for use in cattle producing milk for human consumption.
Presentation
Available in 50ml, 100ml vial.
Storage
Store in a cool and dry place below 25°С, protect from light.
Following withdrawal of the first dose, the product should be used within 28 days.
Validity
3 years.